This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Enlightiks Uses Tableau To Bring Data And Predictive Analytics To Doctors And Accountable Care Organizations

SEATTLE, July 24, 2014 /PRNewswire/ -- Enlightiks, a provider of data and predictive analytics products and services to healthcare providers, is using Tableau to help physicians understand and manage data about their patients and practices. To help its customers navigate the rapidly changing healthcare field, Enlightiks developed an analytics platform, with Tableau at its core, that lets physicians and administrators visualize massive amounts of data on patient history and patterns of care. Critically, the platform also helps physicians make accurate predictions on topics such as patient readmission.
Tableau Software logo

Enlightiks Chief Medical Officer Dr. Bas Nair says that this type of information is vital to the future of the healthcare industry.

"The healthcare industry is undergoing massive change, particularly as the rollout of the Affordable Care Act requires a more technology-driven approach to health," said Dr. Nair. "But most physicians are not 'big data-ready,' nor are they IT experts or fluent in predictive analytics. Tableau is the perfect solution because it is powerful but easy to use and with it, we are able to make this transition much smoother for physicians."

To help physicians keep up with evolving regulations and standards, Enlightiks tracks 33 quality measures and visualizes the information in lightweight Tableau dashboards. These dashboards help private practices, large hospitals, and anything in between track their progress toward these goals.

For instance, Enlightiks' dashboards track readmission rates of patients, broken down by variables like gender, diagnosis, age group, condition, location, and more. In the hands of physicians, this data is a powerful tool to inform decisions about patient care and ultimately to improve patient outcomes. It's also a critical part of compliance to new standards under the Affordable Care Act.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.82 0.13%
FB $102.40 0.48%
GOOG $685.40 0.34%
TSLA $149.45 -0.68%
YHOO $27.12 1.30%


Chart of I:DJI
DOW 15,890.12 +229.94 1.47%
S&P 500 1,854.93 +25.85 1.41%
NASDAQ 4,315.1150 +48.2780 1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs